Affinity Asset Advisors, LLC
Net seller this quarter
$2.21B
101
-$35.4M
39.4%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 ROIV | $133M | 6.00% | 0.52% | +33.9% | Q1 2023 |
| APGE | $131M | 5.92% | 1.31% | -23.2% | Q3 2023 |
 SYRE | $114M | 5.13% | 1.45% | Not reported | Q3 2023 |
 XENE | $96.3M | 4.35% | 1.65% | -4.8% | Q3 2021 |
 ERAS | $96.2M | 4.35% | 1.68% | -1.9% | Q2 2024 |
 INSM | $69.3M | 3.13% | 0.30% | +35.4% | Q2 2024 |
 PRAX | $61.9M | 2.80% | 0.66% | +8.8% | Q4 2025 |
 ALKS | $58.9M | 2.66% | 0.67% | -16.7% | Q3 2023 |
 ORKA | $56.2M | 2.54% | 0.97% | +18.1% | Q3 2024 |
 ANAB | $55.8M | 2.52% | 2.84% | -41.4% | Q4 2025 |
 AVTX | $53.6M | 2.42% | 5.48% | +116.3% | Q1 2024 |
 CYTK | $46.9M | 2.12% | 0.44% | -21.5% | Q4 2020 |
 RVMD | $46.8M | 2.12% | 0.12% | +150.0% | Q3 2025 |
 ABVX | $44M | 1.99% | 0.42% | -18.5% | Q1 2025 |
 TRAX | $40.9M | 1.85% | 5.74% | New | Q2 2026 |
 DNTH | $39M | 1.76% | 0.73% | +14.3% | Q3 2025 |
 STRO | $38.9M | 1.76% | 7.07% | +9.6% | Q4 2020 |
| NUVL | $34M | 1.54% | 8.79% | -8.3% | Q3 2023 |
 TRVI | $33.6M | 1.52% | 1.26% | -10.0% | Q1 2025 |
 OVID | $27.3M | 1.23% | 5.49% | -4.6% | Q1 2025 |
 LXEO | $27M | 1.22% | 7.39% | +15.0% | Q1 2025 |
 CLDX | $26M | 1.18% | 0.89% | +40.0% | Q4 2020 |
 BLTE | $25.4M | 1.15% | 0.42% | +153.9% | Q4 2025 |
 ELVN | $25.4M | 1.15% | 0.68% | -14.8% | Q2 2025 |
| FBRX | $24.3M | 1.10% | 5.59% | +13.2% | Q4 2025 |
 NRIX | $23.5M | 1.06% | 0.93% | Not reported | Q4 2022 |
 ANRO | $22.4M | 1.01% | 2.42% | +70.0% | Q1 2026 |
 MDGL | $21.5M | 0.97% | 0.17% | -27.3% | Q4 2020 |
 PTGX | $21.1M | 0.95% | 0.27% | Not reported | Q1 2021 |
 MLYS | $20.2M | 0.91% | 0.85% | Not reported | Q1 2023 |
 RLAY | $19.6M | 0.89% | 0.48% | +162.5% | Q4 2023 |
 SGMT | $19.3M | 0.87% | 8.14% | +187.8% | Q3 2025 |
 JBIO | $18.7M | 0.84% | 1.32% | +31.3% | Q2 2025 |
 COGT | $17.4M | 0.79% | 0.26% | -40.0% | Q2 2022 |
 TVTX | $17M | 0.77% | 0.32% | Not reported | Q1 2021 |
 CGEM | $15.9M | 0.72% | 1.36% | +12.1% | Q2 2021 |
 SVRA | $15.5M | 0.70% | 1.22% | Not reported | Q3 2023 |
 IDYA | $14.9M | 0.67% | 0.42% | New | Q2 2026 |
 CATX | $14.4M | 0.65% | 3.69% | +33.2% | Q1 2024 |
 ODTX | $14.3M | 0.65% | 1.60% | New | Q2 2026 |
 HLXC | $13.3M | 0.60% | Not reported | Not reported | Q1 2026 |
 EQ | $13.1M | 0.59% | 6.47% | +234.3% | Q1 2026 |
 ESTA | $12.7M | 0.57% | 0.50% | +48.0% | Q1 2021 |
 CLYM | $12.7M | 0.57% | 1.69% | +38.9% | Q2 2024 |
 TEVA | $12.7M | 0.57% | 0.03% | -73.3% | Q2 2023 |
 MANE | $12.3M | 0.56% | 0.24% | +42.9% | Q1 2026 |
 ARWR | $12.2M | 0.55% | 0.11% | -25.0% | Q1 2024 |
 TSHA | $11.9M | 0.54% | 0.54% | +75.0% | Q2 2025 |
 DMRA | $11.1M | 0.50% | 0.69% | -5.6% | Q1 2026 |
 EPRX | $10.9M | 0.49% | 3.18% | +3.8% | Q3 2025 |
| Q1 2026 | |||||
| APGE | $108M | 5.59% | 1.72% | +4.1% | Q3 2023 |
| XENE | $97.4M | 5.03% | 1.73% | +34.0% | Q3 2021 |
| ERAS | $86.6M | 4.47% | 1.72% | +37.2% | Q2 2024 |
| INSM | $78.5M | 4.05% | 0.22% | +6.7% | Q2 2024 |
| ROIV | $77.6M | 4.01% | 0.39% | +64.7% | Q1 2023 |
| SYRE | $64.5M | 3.33% | 1.62% | -10.7% | Q3 2023 |
| CNTA | $55.6M | 2.87% | 0.90% | +133.1% | Q2 2021 |
| PRAX | $54.8M | 2.83% | 0.61% | -8.1% | Q4 2025 |
| ANAB | $52.1M | 2.69% | 3.24% | +111.4% | Q4 2025 |
| ALKS | $47.7M | 2.47% | 0.81% | +35.0% | Q3 2023 |
| CYTK | $46.2M | 2.38% | 0.57% | -12.4% | Q4 2020 |
| ABVX | $45.1M | 2.33% | 0.52% | -19.8% | Q1 2025 |
| TEVA | $42.2M | 2.18% | 0.12% | Not reported | Q2 2023 |
| ACLX | $41.7M | 2.15% | 0.62% | -30.7% | Q2 2022 |
| NUVL | $30.7M | 1.59% | 9.59% | -7.0% | Q3 2023 |
| TERN | $29.7M | 1.53% | 0.49% | +2.3% | Q2 2022 |
| DNTH | $29.4M | 1.52% | 0.64% | +204.4% | Q3 2025 |
| LXEO | $29M | 1.50% | 6.82% | +57.8% | Q1 2025 |
| COGT | $28.9M | 1.49% | 0.44% | +114.3% | Q2 2022 |
| MDGL | $28.8M | 1.49% | 0.24% | +76.7% | Q4 2020 |
| STRO | $26.6M | 1.38% | 6.46% | +42.9% | Q4 2020 |
| FBRX | $26.2M | 1.35% | 7.27% | +2.3% | Q4 2025 |
| ORKA | $24.5M | 1.27% | 1.00% | -37.7% | Q3 2024 |
| TRVI | $23.9M | 1.23% | 1.56% | -7.0% | Q1 2025 |
| OVID | $23.6M | 1.22% | 6.36% | +48.8% | Q1 2025 |
| ELVN | $23M | 1.19% | 0.96% | Not reported | Q2 2025 |
 ASND | $21.7M | 1.12% | 0.15% | +216.7% | Q4 2020 |
| MLYS | $20.3M | 1.05% | 0.91% | +2.7% | Q1 2023 |
| AVTX | $20M | 1.03% | 5.44% | +27.6% | Q1 2024 |
| PTGX | $18.1M | 0.94% | 0.27% | Not reported | Q1 2021 |
| CLDX | $15.9M | 0.82% | 0.75% | +42.9% | Q4 2020 |
 ZURA | $15.3M | 0.79% | 2.70% | +41.4% | Q1 2024 |
| NRIX | $15M | 0.77% | 0.94% | Not reported | Q4 2022 |
| SVRA | $13.7M | 0.71% | 1.23% | -10.2% | Q3 2023 |
| CATX | $13.2M | 0.68% | 2.78% | +954.9% | Q1 2024 |
| HLXC | $12.7M | 0.66% | Not reported | New | Q1 2026 |
| ARWR | $12.5M | 0.65% | 0.14% | +185.7% | Q1 2024 |
| DMRA | $11.7M | 0.60% | 0.75% | New | Q1 2026 |
| EPRX | $11.5M | 0.59% | 3.06% | +429.7% | Q3 2025 |
| ANRO | $11.2M | 0.58% | 1.43% | New | Q1 2026 |
 BBIO | $11.1M | 0.58% | 0.08% | -53.1% | Q4 2020 |
| CGEM | $11.1M | 0.57% | 1.27% | -59.6% | Q2 2021 |
| BLTE | $10.4M | 0.54% | 0.17% | +225.0% | Q4 2025 |
 WVE | $10.2M | 0.52% | 0.73% | -48.1% | Q1 2024 |
 VERA | $10.1M | 0.52% | 0.39% | Not reported | Q1 2024 |
 TYRA | $9.86M | 0.51% | 0.43% | New | Q1 2026 |
| RVMD | $9.73M | 0.50% | 0.05% | Not reported | Q3 2025 |
| JBIO | $8.99M | 0.46% | 1.30% | -10.5% | Q2 2025 |
| TVTX | $8.91M | 0.46% | 0.32% | Not reported | Q1 2021 |
 NAMS | $8.8M | 0.45% | 0.24% | Not reported | Q2 2023 |
| Q4 2025 | |||||
| APGE | $93.2M | 5.31% | 1.81% | +5.2% | Q3 2023 |
| INSM | $78.3M | 4.46% | 0.21% | Not reported | Q2 2024 |
| ABVX | $68.1M | 3.88% | 0.64% | +40.3% | Q1 2025 |
| VTYX | $58.6M | 3.34% | 9.09% | +65.2% | Q3 2022 |
| XENE | $56M | 3.19% | 1.56% | -10.7% | Q3 2021 |
| PRAX | $54.5M | 3.11% | 0.73% | New | Q4 2025 |
| CYTK | $50.8M | 2.90% | 0.65% | +128.6% | Q4 2020 |
| SYRE | $46.9M | 2.67% | 1.83% | +0.9% | Q3 2023 |
| WVE | $45.9M | 2.62% | 1.44% | +28.6% | Q1 2024 |
| TEVA | $43.7M | 2.49% | 0.12% | Not reported | Q2 2023 |
| ROIV | $36.9M | 2.10% | 0.24% | +112.5% | Q1 2023 |
| ACLX | $34.1M | 1.95% | 0.90% | +4.8% | Q2 2022 |
| NUVL | $32.5M | 1.85% | 10.31% | -16.1% | Q3 2023 |
| LXEO | $31.8M | 1.81% | 4.38% | -17.3% | Q1 2025 |
| ALKS | $28M | 1.59% | 0.60% | -20.0% | Q3 2023 |
| FBRX | $27M | 1.54% | 7.64% | New | Q4 2025 |
| TRVI | $26.9M | 1.53% | 1.68% | -23.2% | Q1 2025 |
| MLYS | $26.5M | 1.51% | 0.90% | -2.7% | Q1 2023 |
| BBIO | $24.5M | 1.39% | 0.16% | +392.3% | Q4 2020 |
| ORKA | $24.3M | 1.39% | 1.65% | -16.4% | Q3 2024 |
| TERN | $22.2M | 1.27% | 0.49% | Not reported | Q2 2022 |
| ANAB | $21.6M | 1.23% | 1.59% | New | Q4 2025 |
| CGEM | $20M | 1.14% | 3.21% | +632.4% | Q2 2021 |
| AVTX | $19.1M | 1.09% | 5.68% | +4.5% | Q1 2024 |
| NRIX | $18.4M | 1.05% | 0.95% | Not reported | Q4 2022 |
| TSHA | $18.2M | 1.03% | 1.16% | +10.0% | Q2 2025 |
| MDGL | $18.1M | 1.03% | 0.14% | -72.9% | Q4 2020 |
| SVRA | $16.9M | 0.96% | 1.37% | +86.5% | Q3 2023 |
| PTGX | $15M | 0.86% | 0.28% | -22.0% | Q1 2021 |
| CNTA | $15M | 0.86% | 0.40% | -45.8% | Q2 2021 |
| ESTA | $14.6M | 0.83% | 0.68% | -35.5% | Q1 2021 |
| ERAS | $14.5M | 0.83% | 1.37% | -9.0% | Q2 2024 |
| VERA | $12.7M | 0.72% | 0.39% | -17.6% | Q1 2024 |
| COGT | $12.4M | 0.71% | 0.22% | Not reported | Q2 2022 |
| OVID | $11.7M | 0.66% | 5.49% | +169.8% | Q1 2025 |
| TVTX | $11.5M | 0.65% | 0.33% | -40.0% | Q1 2021 |
| JBIO | $11M | 0.63% | 1.45% | +994.6% | Q2 2025 |
| NAMS | $9.65M | 0.55% | 0.24% | Not reported | Q2 2023 |
| CLDX | $9.51M | 0.54% | 0.53% | +16.7% | Q4 2020 |
| ZURA | $9.5M | 0.54% | 2.46% | +42.3% | Q1 2024 |
 TNGX | $8.86M | 0.50% | 0.74% | Not reported | Q3 2021 |
| STRO | $8.66M | 0.49% | 8.72% | +894.2% | Q4 2020 |
| RVMD | $7.97M | 0.45% | 0.05% | Not reported | Q3 2025 |
 MBX | $7.89M | 0.45% | 0.56% | +51.5% | Q1 2025 |
 VRDN | $7.78M | 0.44% | 0.25% | Not reported | Q1 2022 |
 RCUS | $7.15M | 0.41% | 0.24% | New | Q4 2025 |
| SGMT | $6.8M | 0.39% | 3.74% | +228.1% | Q3 2025 |
 KPTI | $6.55M | 0.37% | 4.86% | Not reported | Q4 2022 |
| ASND | $6.4M | 0.36% | 0.05% | Not reported | Q4 2020 |
 VRCA | $5.88M | 0.33% | 4.12% | New | Q4 2025 |
| Q3 2025 | |||||
| VRNA | $66.7M | 5.81% | 0.09% | +2.5% | Q3 2022 |
| INSM | $64.8M | 5.65% | 0.21% | -5.3% | Q2 2024 |
 SPY | $56.3M | 4.90% | Not reported | Not reported | Q1 2025 |
| XENE | $56.2M | 4.90% | 1.82% | +27.3% | Q3 2021 |
| MDGL | $52.7M | 4.59% | 0.51% | +43.8% | Q4 2020 |
| APGE | $46.6M | 4.06% | 1.98% | +69.6% | Q3 2023 |
| ACLX | $41.1M | 3.58% | 0.87% | +1.0% | Q2 2022 |
| ALKS | $37.5M | 3.27% | 0.76% | +25.0% | Q3 2023 |
| NUVL | $33.2M | 2.90% | 12.28% | -7.4% | Q3 2023 |
| ABVX | $30.6M | 2.66% | 0.57% | +260.0% | Q1 2025 |
| MLYS | $28.4M | 2.48% | 0.95% | -16.7% | Q1 2023 |
| TEVA | $28.3M | 2.46% | 0.12% | Not reported | Q2 2023 |
| MRUS | $26.9M | 2.34% | 0.38% | +308.2% | Q2 2024 |
| CNTA | $26.8M | 2.34% | 0.82% | +23.0% | Q2 2021 |
| LXEO | $25.7M | 2.24% | 7.05% | +7.8% | Q1 2025 |
| TRVI | $25.6M | 2.23% | 2.18% | +10.5% | Q1 2025 |
| SYRE | $23.8M | 2.07% | 2.35% | +134.0% | Q3 2023 |
 RZLT | $19.7M | 1.72% | 2.31% | -4.6% | Q1 2024 |
| CYTK | $19.2M | 1.68% | 0.29% | Not reported | Q4 2020 |
| ORKA | $18.4M | 1.61% | 1.98% | +58.9% | Q3 2024 |
 QURE | $17.5M | 1.53% | 0.48% | +122.2% | Q1 2025 |
| WVE | $15.4M | 1.34% | 1.31% | +5.0% | Q1 2024 |
| PTGX | $14.7M | 1.28% | 0.35% | -49.9% | Q1 2021 |
| SLNO | $13.5M | 1.18% | 0.37% | Not reported | Q3 2024 |
| AVTX | $12.8M | 1.11% | 5.64% | +65.5% | Q1 2024 |
| ESTA | $12.7M | 1.11% | 1.07% | -7.4% | Q1 2021 |
| VTYX | $12.2M | 1.06% | 5.50% | -13.5% | Q3 2022 |
| ROIV | $12.1M | 1.05% | 0.12% | +100.0% | Q1 2023 |
| TVTX | $12M | 1.04% | 0.56% | -48.5% | Q1 2021 |
| DNTH | $10.3M | 0.90% | 0.61% | New | Q3 2025 |
| TSHA | $9.81M | 0.85% | 1.10% | +1400.0% | Q2 2025 |
| ERAS | $9.34M | 0.81% | 1.51% | +4.9% | Q2 2024 |
| NRIX | $8.94M | 0.78% | 1.26% | Not reported | Q4 2022 |
| VERA | $8.81M | 0.77% | 0.48% | -44.3% | Q1 2024 |
| ELVN | $8.19M | 0.71% | 0.68% | Not reported | Q2 2025 |
| NAMS | $7.82M | 0.68% | 0.24% | Not reported | Q2 2023 |
| CLDX | $7.76M | 0.68% | 0.45% | Not reported | Q4 2020 |
 PRQR | $7.67M | 0.67% | 3.42% | +2.9% | Q4 2024 |
 TARS | $7.43M | 0.65% | 0.29% | New | Q3 2025 |
 AKBA | $6.69M | 0.58% | 0.92% | +25.6% | Q1 2025 |
 MNPR | $6.49M | 0.57% | 1.19% | +17.8% | Q1 2025 |
| ZURA | $5.52M | 0.48% | 1.96% | +470.6% | Q1 2024 |
| VRDN | $5.4M | 0.47% | 0.30% | -35.9% | Q1 2022 |
| SVRA | $5.36M | 0.47% | 0.87% | +200.0% | Q3 2023 |
 IMVT | $4.84M | 0.42% | 0.17% | Not reported | Q4 2020 |
| RVMD | $4.67M | 0.41% | 0.05% | New | Q3 2025 |
 PCVX | $4.5M | 0.39% | 0.10% | Not reported | Q4 2020 |
| NAMSW | $4.19M | 0.37% | Not reported | Not reported | Q1 2023 |
 FRNM | $3.76M | 0.33% | 3.93% | Not reported | Q2 2024 |
 INSP | $3.71M | 0.32% | 0.17% | Not reported | Q3 2023 |